dc.contributor.author |
Elkıran, Özlem |
|
dc.contributor.author |
Karakurt, Cemşit |
|
dc.contributor.author |
Koçak, Gülendam |
|
dc.contributor.author |
Tabel, Yılmaz |
|
dc.contributor.author |
Güngör, Serdal |
|
dc.date.accessioned |
2017-08-23T10:39:51Z |
|
dc.date.available |
2017-08-23T10:39:51Z |
|
dc.date.issued |
2015 |
|
dc.identifier.citation |
Elkıran, Ö. Karakurt, C. Koçak, G. Tabel, Y. Güngör, S. (2015). Possible association between fluconazole administration and acute hyperkalemia in a critically ill cyanotic infant . Arch Med Sci, 11(1), 235–236. |
tr_TR |
dc.identifier.uri |
http://hdl.handle.net/11616/7684 |
|
dc.description.abstract |
Fluconazole, an azole antifungal agent, inhibits the fungal cytochrome
P450 enzyme. Although in vitro data show that fluconazole is not a potent
inhibitor of mammalian P450 enzymes, hyperkalemia secondary to
adrenal insufficiency associated with fluconazole has been described
rarely [1–3]. However, life-threatening severe hyperkalemia related to administration
of intravenous fluconazole without adrenal suppression has
not been reported before. |
tr_TR |
dc.language.iso |
eng |
tr_TR |
dc.publisher |
Arch Med Sci |
tr_TR |
dc.relation.isversionof |
10.5114/aoms.2015.49215 |
tr_TR |
dc.rights |
info:eu-repo/semantics/openAccess |
tr_TR |
dc.title |
Possible association between fluconazole administration and acute hyperkalemia in a critically ill cyanotic infant |
tr_TR |
dc.type |
article |
tr_TR |
dc.relation.journal |
Arch Med Sci |
tr_TR |
dc.contributor.department |
İnönü Üniversitesi |
tr_TR |
dc.contributor.authorID |
113274 |
tr_TR |
dc.identifier.volume |
11 |
tr_TR |
dc.identifier.issue |
1 |
tr_TR |
dc.identifier.startpage |
235 |
tr_TR |
dc.identifier.endpage |
236 |
tr_TR |